Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02623712 · ClinicalTrials.gov registry record · NA
The Watch the Spot Trial
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 34,686
- Enrollment target
NCT02623712: Completed NA study, sponsored by Kaiser Permanente.
NCT02623712 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 34,686 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2372% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02623712, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 34,686 participants
- Enrollment target
Study Summary
This study will compare two clinically accepted protocols for surveillance imaging in individuals who are found to have a small pulmonary nodule on chest computed tomography (CT) scans.
Primary Outcome
Among individuals with small pulmonary nodules identified either incidentally or by screening, compare more versus less intensive surveillance to determine the number of cancerous nodules that progress beyond T stage T1a.
Interventions
- OTHER More Frequent Surveillance Strategy
- OTHER Less Frequent Surveillance Strategy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34,686 participants |
| Start Date | 2017-03-06 |
| Est. Completion | 2024-09-04 |
| Phase | NA |
What the finished NCT02623712 record still lists
NCT02623712 is an interventional study that assigns participants to a tested intervention. Its 34,686 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2372% higher).
The record links to 0 conditions, and to 2 interventions - of which More Frequent Surveillance Strategy is the first listed.
NCT02623712 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02623712 about?
NCT02623712 is a clinical study titled "The Watch the Spot Trial". This study will compare two clinically accepted protocols for surveillance imaging in individuals who are found to have a small pulmonary nodule on chest computed tomography (CT) scans.
What is the current status of trial NCT02623712?
This trial is currently completed. It is a NA study. The enrollment target is 34,686 participants. The study started on 2017-03-06. Estimated completion is 2024-09-04.
What interventions are being tested in trial NCT02623712?
The interventions under investigation include: More Frequent Surveillance Strategy (OTHER), Less Frequent Surveillance Strategy (OTHER).
Who is sponsoring clinical trial NCT02623712?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02623712's enrollment target sits among peer trials
34,686 8th of 2000 higher than 1,993 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03720613 · 34,532 participants
Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
- NCT02225301 · 35,000 participants · NA
iLookOut for Child Abuse -Online Learning Module for Early Childcare Providers
- NCT03262259 · 36,000 participants · NA
Evaluation of Global Smart Drinking Goals Initiative
- NCT06145724 · 33,183 participants · NA
EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI